• Zea2LLC

Jeff Lievense

Biotechnology Scale-up Pioneer

As founder and CEO of Lievense Bioengineering and in that capacity serves as an advisor to several biotechnology companies. Previously, he was Senior Advisor to the CEO, Bioengineering & Technology, at Genomatica, a leader in commercial development of biobased process technologies for chemical production.

"Scaling up fermentation processes can require more time and investment than for R&D. Smart scale-up begins with the end in mind; is diligent in the details; and prepares for the unexpected"

Jeff has decades of industrial metabolic engineering, fermentation process development, and scale-up experience at several companies spanning a range of products, including landmark achievements in the field: 1,4-butanediol (Genomatica), farnesene (Amyris), 1,3-propanediol (Tate & Lyle), and indigo (Kodak-Genencor).

Thought leader and educator

For years he served as lead instructor for a UC-San Diego short course on Microbial Fermentation and a contributing instructor to another course on Metabolic Engineering. He organized and co-chaired the first conference on Commercializing Industrial Biotechnology, sponsored by AIChE’s Society for Biological Engineering. Jeff has been recognized for excellence in the field as a recipient of Purdue University’s Outstanding Chemical Engineer Award (2014); SIMB’s Raphael Katzen Award (2018); AIChE’s Fellow status (2018); and National Academy of Engineering Member status (2019). or relevant content. In 2016, Biofuels Digest named him one of the Top 100 People in the Advanced Bioeconomy.

He earned B.S. and Ph.D. degrees in chemical engineering from the University of Michigan and Purdue University, respectively.




© 2020 by ZEA2 LLC - a wholly owned subsidiary of Sustainable Conversion Ventures

  • White YouTube Icon
  • White Twitter Icon